Remedy Robotics Inc.

Based in the US, Remedy Robotics Inc. specializes in innovative surgical solutions, particularly in cardiovascular care, enhancing operational efficiencies through its remotely operated robotic systems. Founded in 2021 and headquartered in San Francisco, US, Remedy Robotics Inc. develops advanced robotic solutions for surgical applications.

The company remains privately held and has successfully raised USD 35. 00 mn through a funding round completed in October 2025. The founder's history is not publicly detailed, and there have been no noted pivots in business strategy or operations to date. Remedy Robotics specializes in providing surgical solutions aimed at enhancing patient care in cardiovascular treatments.

The company has developed the world’s first remotely operated endovascular robot, designed to deliver timely and precise interventions for conditions such as stroke and heart attacks. This system enables hospitals, regardless of their onsite expertise, to perform life-saving procedures without delay. Key markets for their products include hospitals and medical facilities globally, particularly in Australia, where they have established strategic partnerships with leading healthcare organizations like the Australian Stroke Alliance. By integrating advanced medical imaging data with deep neural network models, Remedy Robotics enhances the robot’s ability to navigate complex anatomical structures for effective patient interventions worldwide.

Remedy Robotics operates within a B2B framework, primarily engaging with hospitals and healthcare institutions for the deployment of its endovascular robotic system. The company’s flagship product likely operates on a structure involving initial installation fees, ongoing service agreements, and potentially a subscription-based model for software updates and maintenance. This revenue structure is designed to enable hospitals to offer high-quality cardiovascular interventions while benefiting from ongoing technological advancements provided by Remedy Robotics. In October 2025, Remedy Robotics Inc.

raised an undisclosed amount of series A funding from Blackbird, Build Collective, and KdT Ventures. The company plans to utilize the October 2025 funding for technology development and team expansion including engineering, software development, and clinical trial management.